$NWE Balance Sheet | Understand Stock

$NWE

$78.45 +$0.86 (1.11%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023
ASSETS
Current Assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventories
Regulatory assets
Prepaid expenses and other
Total current assets
Property, plant, and equipment, net
Goodwill
Regulatory assets
Other noncurrent assets
Total Assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Current maturities of finance leases
Current portion of long-term debt
Short-Term Debt
Accounts payable
Accrued expenses and other
Regulatory liabilities
Total current liabilities
Long-term finance leases
Long-term debt
Deferred income taxes
Noncurrent regulatory liabilities
Other noncurrent liabilities
Total Liabilities
Shareholders' Equity:
Common Stock, Value, Issued
Treasury stock at cost
Paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total Shareholders' Equity
Total Liabilities and Shareholders' Equity
Preferred Stock, Shares Issued
Common Stock, Par or Stated Value Per Share
Common Stock, Shares Authorized
Common Stock, Shares, Issued
Common Stock, Shares, Outstanding
Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Shares Authorized
Preferred Stock, Shares Outstanding

Comments